Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Novel CRM1 Inhibitor Prevent the Nuclear Export of Beclin-1 Blocks Autophagy in Mantle Cell Lymphoma

Kejie Zhang, MD PhD, Yuhan Chen, MD, Yongli Zhang, MD, Qin Yao, MDPhD, Huiqin Zhuo, PhD

Blood (2014) 124 (21): 3596.

https://doi.org/10.1182/blood.V124.21.3596.3596

Published: 2014

Journal Articles

Reversing Metabolic and Epigenetic Cellular Alterations to Overcome Chemo-Resistance in Aggressive B Cell Lymphomas

Kejie Zhang, MD, PhD, Lan V Pham, PhD, Archito T. Tamayo, MS, John Lee, MD, Jerry Bryant, M.S., Anas Younes, MD, Luis E Fayad, MD, David J Yang, Ph.D, Richard J. Ford, MD, PhD

Blood (2012) 120 (21): 1305.

https://doi.org/10.1182/blood.V120.21.1305.1305

Published: 2012

Journal Articles

Novel CRM-1 Inhibitors for Therapy In Mantle Cell Lymphoma

Kejie Zhang, MD, PhD, Lan V Pham, PhD, Liang Zhang, MD, PhD, Archito T. Tamayo, MS, Zhishuo Ou, MD, Dilara McCauley, PhD, Sharon Shacham, PhD, Michael Kauffman, MD, PhD, Richard J. Ford, MD, PhD, Michael Wang, MD

Blood (2011) 118 (21): 2734.

https://doi.org/10.1182/blood.V118.21.2734.2734

Published: 2011

Journal Articles

Carfilzomib, An Irreversible Proteasome Inhibitor, Induces Long-Term Growth Inhibition of Mantle Cell Lymphoma In Vivo,

Liang Zhang, MD, PhD, Jianfei Qian, PhD, Zhishuo Ou, MD, Luhong Sun, MD, PhD, Kejie Zhang, MD, PhD, Lan V Pham, PhD, Christopher J Kirk, PhD, Richard J. Ford, MD, PhD, Qing Yi, MD, PhD, Michael Wang, MD

Blood (2011) 118 (21): 3740.

https://doi.org/10.1182/blood.V118.21.3740.3740

Published: 2011

Journal Articles

Single-Agent Bruton's Tyrosine Kinase (Btk) Inhibitor and Single-Agent Carfilzomib Induce Cell Apoptosis, Arrest Cell Growth and Downregulate NF-Kb Activity In Mantle Cell Lymphoma

Zhishuo Ou, MD, Lan V Pham, PhD, Liang Zhang, MD, PhD, Archito T. Tamayo, MS, John Lee, MD, Kejie Zhang, MD, PhD, Jacqueline Wang, James Phan, Changping Li, MD, Luhong Sun, MD, PhD, Richard J. Ford, MD, PhD, Michael Wang, MD

Blood (2011) 118 (21): 4971.

https://doi.org/10.1182/blood.V118.21.4971.4971

Published: 2011

NARROW

Novel CRM1 Inhibitor Prevent the Nuclear Export of Beclin-1 Blocks Autophagy in Mantle Cell Lymphoma

Reversing Metabolic and Epigenetic Cellular Alterations to Overcome Chemo-Resistance in Aggressive B Cell Lymphomas

Novel CRM-1 Inhibitors for Therapy In Mantle Cell Lymphoma

Carfilzomib, An Irreversible Proteasome Inhibitor, Induces Long-Term Growth Inhibition of Mantle Cell Lymphoma In Vivo,

Single-Agent Bruton's Tyrosine Kinase (Btk) Inhibitor and Single-Agent Carfilzomib Induce Cell Apoptosis, Arrest Cell Growth and Downregulate NF-Kb Activity In Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Novel CRM1 Inhibitor Prevent the Nuclear Export of Beclin-1 Blocks Autophagy in Mantle Cell Lymphoma

Reversing Metabolic and Epigenetic Cellular Alterations to Overcome Chemo-Resistance in Aggressive B Cell Lymphomas

Novel CRM-1 Inhibitors for Therapy In Mantle Cell Lymphoma

Carfilzomib, An Irreversible Proteasome Inhibitor, Induces Long-Term Growth Inhibition of Mantle Cell Lymphoma In Vivo,

Single-Agent Bruton's Tyrosine Kinase (Btk) Inhibitor and Single-Agent Carfilzomib Induce Cell Apoptosis, Arrest Cell Growth and Downregulate NF-Kb Activity In Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only